Dalbavancin in Real Clinical Practice in Spain

CompletedOBSERVATIONAL
Enrollment

187

Participants

Timeline

Start Date

July 15, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

February 21, 2021

Conditions
Skin Diseases, BacterialSkin Diseases, Infectious
Trial Locations (7)

15006

Hospital Universitario A Coruña, A Coruña

18014

Hospital Universitario Virgen de las Nieves, Granada

28007

Hospital General Universitario Gregorio Marañón, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

46026

Hospital Universtario La Fe, Valencia

08035

Hospital Universitari Vall d'Hebrón, Barcelona

08036

Hospital Clínic Barcelona, Barcelona

Sponsors
All Listed Sponsors
collaborator

Effice Servicios Para la Investigacion S.L.

INDUSTRY

lead

Angelini Farmacéutica

INDUSTRY

NCT04485676 - Dalbavancin in Real Clinical Practice in Spain | Biotech Hunter | Biotech Hunter